895 related articles for article (PubMed ID: 23688540)
1. Pharmacists' performance of clinical interventions during adherence support medication reviews.
Hatah E; Tordoff J; Duffull SB; Braund R
Res Social Adm Pharm; 2014; 10(1):185-94. PubMed ID: 23688540
[TBL] [Abstract][Full Text] [Related]
2. Performance of community pharmacists in providing clinical medication reviews.
Laaksonen R; Duggan C; Bates I
Ann Pharmacother; 2010; 44(7-8):1181-90. PubMed ID: 20571102
[TBL] [Abstract][Full Text] [Related]
3. Examining the first year of Medicines Use Review services provided by pharmacists in New Zealand: 2008.
Lee E; Braund R; Tordoff J
N Z Med J; 2009 Apr; 122(1293):3566. PubMed ID: 19448788
[TBL] [Abstract][Full Text] [Related]
4. Effect of medication review and cognitive behaviour treatment by community pharmacists of patients discharged from the hospital on drug related problems and compliance: design of a randomized controlled trial.
Ahmad A; Hugtenburg J; Welschen LM; Dekker JM; Nijpels G
BMC Public Health; 2010 Mar; 10():133. PubMed ID: 20230611
[TBL] [Abstract][Full Text] [Related]
5. Completeness of medication reviews provided by community pharmacists.
Kwint HF; Faber A; Gussekloo J; Bouvy ML
J Clin Pharm Ther; 2014 Jun; 39(3):248-52. PubMed ID: 24521180
[TBL] [Abstract][Full Text] [Related]
6. Understanding the patient perspective of the English community pharmacy Medicines Use Review (MUR).
Latif A; Boardman HF; Pollock K
Res Social Adm Pharm; 2013; 9(6):949-57. PubMed ID: 23506650
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the clinical and economic outcomes of pharmacy interventions in drug-related problems.
Westerlund T; Marklund B
J Clin Pharm Ther; 2009 Jun; 34(3):319-27. PubMed ID: 19646078
[TBL] [Abstract][Full Text] [Related]
8. The contribution of patient interviews to the identification of drug-related problems in home medication review.
Kwint HF; Faber A; Gussekloo J; Bouvy ML
J Clin Pharm Ther; 2012 Dec; 37(6):674-80. PubMed ID: 22861493
[TBL] [Abstract][Full Text] [Related]
9. Implementation of a pharmacist medication review clinic for haemodialysis patients.
Mirkov S
N Z Med J; 2009 Jun; 122(1297):25-37. PubMed ID: 19648999
[TBL] [Abstract][Full Text] [Related]
10. Implementation of targeted medication adherence interventions within a community chain pharmacy practice: The Pennsylvania Project.
Bacci JL; McGrath SH; Pringle JL; Maguire MA; McGivney MS
J Am Pharm Assoc (2003); 2014; 54(6):584-93. PubMed ID: 25379980
[TBL] [Abstract][Full Text] [Related]
11. Randomised evaluation of the Italian medicines use review provided by community pharmacists using asthma as a model (RE I-MUR).
Manfrin A; Thomas T; Krska J
BMC Health Serv Res; 2015 Apr; 15():171. PubMed ID: 25896873
[TBL] [Abstract][Full Text] [Related]
12. Drug related problems identified by European community pharmacists in patients discharged from hospital.
Paulino EI; Bouvy ML; Gastelurrutia MA; Guerreiro M; Buurma H;
Pharm World Sci; 2004 Dec; 26(6):353-60. PubMed ID: 15683106
[TBL] [Abstract][Full Text] [Related]
13. Survey of drug-related problems identified by community pharmacies.
Hämmerlein A; Griese N; Schulz M
Ann Pharmacother; 2007 Nov; 41(11):1825-32. PubMed ID: 17925500
[TBL] [Abstract][Full Text] [Related]
14. Perceptions of patients on Medicare Part D medication therapy management services.
Truong HA; Layson-Wolf C; de Bittner MR; Owen JA; Haupt S
J Am Pharm Assoc (2003); 2009; 49(3):392-8. PubMed ID: 19443319
[TBL] [Abstract][Full Text] [Related]
15. Analysis of pharmacist-provided medication therapy management (MTM) services in community pharmacies over 7 years.
Barnett MJ; Frank J; Wehring H; Newland B; VonMuenster S; Kumbera P; Halterman T; Perry PJ
J Manag Care Pharm; 2009; 15(1):18-31. PubMed ID: 19125547
[TBL] [Abstract][Full Text] [Related]
16. General practitioners' views of pharmacists' current and potential contributions to medication review and prescribing in New Zealand.
Hatah E; Braund R; Duffull SB; Tordoff J
J Prim Health Care; 2013 Sep; 5(3):223-33. PubMed ID: 23998173
[TBL] [Abstract][Full Text] [Related]
17. Follow-up of patients receiving a pharmaceutical care service in Sweden.
Montgomery AT; Sporrong SK; Tully MP; Lindblad AK
J Clin Pharm Ther; 2008 Dec; 33(6):653-62. PubMed ID: 19138243
[TBL] [Abstract][Full Text] [Related]
18. Retrospective examination of selected outcomes of Medicines Use Review (MUR) services in New Zealand.
Hatah E; Tordoff J; Duffull SB; Cameron C; Braund R
Int J Clin Pharm; 2014 Jun; 36(3):503-12. PubMed ID: 24626968
[TBL] [Abstract][Full Text] [Related]
19. Classification of drug-related problems with new prescriptions using a modified PCNE classification system.
Eichenberger PM; Lampert ML; Kahmann IV; van Mil JW; Hersberger KE
Pharm World Sci; 2010 Jun; 32(3):362-72. PubMed ID: 20229029
[TBL] [Abstract][Full Text] [Related]
20. Drug-related problems identified by pharmacists conducting medication use reviews at a primary health center in Qatar.
Kheir N; Awaisu A; Sharfi A; Kida M; Adam A
Int J Clin Pharm; 2014 Aug; 36(4):702-6. PubMed ID: 24965594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
